Intra-Cellular Therapies (ITCI) PT Raised to $38 at BTIG
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Price: $131.87 --0%
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 30
Join SI Premium – FREE
BTIG raised its price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $38.00 (from $36.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Philip Morris (PM) PT Raised to $193 at UBS, Neutral Rating Maintained
- EQ Resources Limited (EQR:AU) PT Raised to AUD0.55 at Canaccord
- AutoZone (AZO) PT Lowered to $3,500 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
The Children's Investment Fund (TCI), BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
